Journal of Medicinal Chemistry · 2006 · 42 citations · 6 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCytotoxic ChemotherapyOncology PharmacologyTyrosine Kinase InhibitorsKinase InhibitorsPhosphoinositide 3-Kinase PathwayPhosphoinositide 3-Kinase SignalingPi3k InhibitorsPi3k SignalingTherapeutic Index Determination
Phosphoinositide 3-kinase (PI3K) is an important target for cancer chemotherapy due to the deregulation of its signaling pathway in a wide spectrum of human tumors. Wortmannin and its analogues are potent PI3K inhibitors whose therapeutic use has been impeded by inherent defects such as instability and toxicity. Pegylation of wortmannin and 17-hydroxywortmannin gives rise to conjugates with improved properties, including a higher therapeutic index. Pegylated 17-hydroxywortmannin (8, PWT-458) has been selected for further development.
6
Matthias P. Wymann, Ginette Bulgarelli-Leva, Marketa Zvelebil et al. · Molecular and Cellular Biology · 1996 · 680 citations · Full text